Snag Walgreen Before it Catches Up
Walgreen's (WAG) now-resolved spat with Express Scripts (ESRX) was well-publicized. The dispute hurt earnings, and it will contribute to lesser prescription-drug sales over the next three or four quarters, as compared with the previous year.
Stock-market prices generally discount all known information, and a good example lies here: After the initial lack of an agreement with Express Scripts, Walgreen shares fell to $28.53 from their 2011 peak of $47.10. They then rebounded to about $37 in early September....325 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.
